Sheppard Mullin advised Signet Healthcare Partners on the deal.Paragonix Technologies, Inc., a leading organ transplant company, announced that it has secured $24 million in Series B…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
